SureTrader Nadex Advertisement
Home > Boards > US OTC > Biotechs >

Abattis Bioceuticals Corp. (ATTBF)

ATTBF RSS Feed
Add ATTBF Price Alert      Hide Sticky   Hide Intro
Moderator: Goodbuddy4863, guay, ebota12, GreenBrickRoad
Search This Board: 
Last Post: 2/27/2017 6:57:43 PM - Followers: 294 - Board type: Free - Posts Today: 33




Welcome to Abattis Bioceuticals Corp.


Abattis Bioceuticals Corp. (the "Company" or "Abattis") (OTCQB: ATTBF) (CSE: ATT), is a specialty biotechnology company with capabilities through its wholly-owned subsidiaries as a botanical drug development company that develops and licenses natural health products, medicines, extractions and ingredients for the biologics, nutraceutical, bioceutical and cosmetic markets, some of which will contain cannabinoid compounds. Abattis develops and is in the process of commercializing natural health products that target ailments and satisfy important market needs. Abattis is conducting ongoing research and development to create plant-based intellectual property and ingredients. Current areas of focus are growth through acquisition and business development and cash flow through commercialization of existing assets.

Through our divisions Biocell Labs Inc. and Vergence Sales & Marketing Group, we develop and license natural health products and have future plans to expand into the nutraceutical, pharmaceutical and cosmetic markets. The Company has an extensive pipeline of high-quality products and intellectual property for the rapidly expanding natural health product market. We follow strict standard operating protocols, and adhere to the applicable laws of Canada and foreign jurisdictions.





Within our other divisions Northern Vine, North American Bioextracts and Biocube we have capabilities that support the production and extraction of botanical ingredients for our products; one of which includes cannabis.

Northern Vine LaboratoriesTM (Northern Vine Labs
TM) seeks to become the premier analytical testing laboratory, and research and development partner to the legal cannabis industry in Canada - Executive Overview

For more information, visit the Company's website at: www.abattis.com.





Our investors are forward thinkers in the emerging bioceutical and medical marijuana markets. We are a specialty, vertically-integrated biotechnology company that aggregates, incubates, integrates and invests in the natural health product and botanical drug development industry. From patented and proprietary formulations, extraction and processing methods, Abattis consistently seeks opportunities to participate in varied markets all connected by a common global purpose and customer base: seeking health through natural products. Abattis is uniquely positioned to fully exploit the growing trend toward marijuana legalization in the United States and medicinal use in Canada as licensed and international jurisdictions.

“Health Canada estimates that the emerging medical marijuana market to be in excess of $1 billion.
Stephen Easton, an SFU Economist, estimated that nationally the Cannabis industry generates approximately $19 to $21 billion”


We develop and license natural health products with unique botanical blends, CBD and proprietary ingredients. These infused food and beverage brands are designed for wellness nutraceuticals, medical foods & botanical drugs market with future plans to expand into the pharmaceutical and cosmetic markets.

As an investor, you are our partner and we take this relationship seriously. Please contact us if you have any questions or if you would like to invest in Abattis.
 

Goldman Small Cap Research report, 'This Stock Set to Double Thanks to New License'
Abattis Bioceuticals Corp. - Stock Up Big on Recent News, Greater Gains on Horizon (October 20, 2016).

Goldman Small Cap Research report 
'The Next Industry-Changing Specialty Health Stock'
Abattis Bioceuticals Corp. - Major Revenue Ahead for Innovative, Diversified Bioceuticals Pioneer (June 13, 2016).

Northern Vine
Phone: (604) 371.3371 | 
(604) 316.0982 (604) 888.1129

CHINA | Dr. Shuang Xie  Ph. D.
Suzhou Raybot Material Tech Ltd
T: 17785884380 | C: 17783175968
Phone: 86 5125240581 | 8613901388668
Address:  No. 10-1 Yang Yuan Road,
Xinzhuang Zhen,Changshu | China



OUTSTANDING COMMON SHARE DATA
There are an unlimited number of common shares without par value authorized for issue. At September 30, 2016, there were 111,760,004 issued and fully paid common shares and 1,750,000 common shares in treasury.

Issued & Outstanding: The Company has 135,344,679 common shares issued and outstanding, 9,060,000 share purchase options outstanding and 17,101,425 share purchase warrants outstanding. On a fully diluted basis, 161,506,107, common shares were outstanding. 
(Effective: 09/30/2016)
 

System for Electronic Document Analysis and Retrieval (SEDAR) - www.sedar.com
 





If you want to add or to change something on this site - send a message to guay.
 
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
ATTBF
Current Price
Volume:
Bid Ask Day's Range
SureTrader
ATTBF News: Withdrawal of Registration Statement (rw) 12/09/2016 06:05:17 AM
PostSubject
#27284  Sticky Note Goldman Research thinks ATTBF could blow through $0.30+ GreenBrickRoad 10/21/16 11:19:22 AM
#27151  Sticky Note Abattis Bioceuticals (ATTBF) Experion Biotechnologies Prepares for Construction guay 10/17/16 10:22:27 AM
#27144  Sticky Note 'The Next Industry-Changing Specialty Health Stock' guay 10/14/16 04:30:32 PM
#26399  Sticky Note Corporate Update ebota12 11/05/15 07:31:44 PM
#12064  Sticky Note BOARD WARNING - Please Read: IH Admin [Shelly] 06/09/14 01:18:32 PM
#28158   https://www.abattis.com/news hans1111 02/27/17 06:57:43 PM
#28157   The Trump administration is already creating an environment jjr04001 02/27/17 06:21:20 PM
#28156   USD to CAD is about 1.32 right now, GreenBrickRoad 02/27/17 05:51:28 PM
#28155   Well, I wouldn't be surprised if Abattis draws GreenBrickRoad 02/27/17 05:46:16 PM
#28154   So when it reopens for trading it will Atom Smasher 02/27/17 05:44:56 PM
#28153   ATTBF on the U.S. OTCQB is trading and GreenBrickRoad 02/27/17 05:38:20 PM
#28152   They will, and they're also going to state ebota12 02/27/17 05:38:16 PM
#28151   It's not trading on the CSE? It Atom Smasher 02/27/17 05:34:33 PM
#28150   I'd think they would PR, too. BIGKAHUNA57 02/27/17 04:52:50 PM
#28149   And I'm curious on other's opinions here, but GreenBrickRoad 02/27/17 04:27:52 PM
#28148   Gracias snake. tomadam 02/27/17 04:15:18 PM
#28147   http://thecse.com/en/listings/life-sciences/abattis-bioceuticals-corp Scroll Solidsnake10 02/27/17 04:06:39 PM
#28146   No, I'm not sure what's confusing you at GreenBrickRoad 02/27/17 04:02:33 PM
#28145   I see where they self filed on the tomadam 02/27/17 04:00:22 PM
#28144   Those emails were right.... ebota12 02/27/17 03:59:55 PM
#28143   The company didn't specifically say in any PR GreenBrickRoad 02/27/17 03:56:14 PM
#28142   You probably shouldn't be investing if using google Solidsnake10 02/27/17 03:55:26 PM
#28141   GBR, ther are nothing in links you gave tomadam 02/27/17 03:54:54 PM
#28140   Just went to abattis website again green, and tomadam 02/27/17 03:50:53 PM
#28139   The 2016 annual report for ATTBF and other GreenBrickRoad 02/27/17 03:50:32 PM
#28138   Thanks for that info green tomadam 02/27/17 03:47:47 PM
#28137   Tom you really have to rely less on GreenReality 02/27/17 03:38:11 PM
#28136   Says "completion" of audit, notice the careful wording, tomadam 02/27/17 03:38:10 PM
#28135   Yes - And 'Seattle' is not 'Lebuhraya Kuala guay 02/27/17 03:29:53 PM
#28134   Has anyone heard when a formal announcement will tomadam 02/27/17 03:24:50 PM
#28133   They did last week... BCSC still has to StarFishPatrick 02/27/17 03:04:33 PM
#28132   Do you think they have anyone leftover from StarFishPatrick 02/27/17 03:03:43 PM
#28131   When the f....k are they gonna file the tomadam 02/27/17 02:08:47 PM
#28130   The big players are loading for another rocketship. GreenReality 02/27/17 11:43:59 AM
#28129   Weird action today. The price is kind of GreenBrickRoad 02/27/17 11:38:40 AM
#28128   The Future of Abattis guay 02/27/17 11:22:51 AM
#28127   ATTBF is stabilizing and getting ready for another SeeingGreen420 02/27/17 10:36:54 AM
#28126   Do You think they sold all the machines guay 02/27/17 10:22:33 AM
#28125   Remember the news, all signs point to ATTBF SeeingGreen420 02/26/17 06:32:33 PM
#28124   Nitric oxide increasing nutritional supplements and methods guay 02/26/17 05:33:25 PM
#28123   Nope - they lost it. StarFishPatrick 02/26/17 04:44:07 PM
#28122   Volume? Potential? Future of the company? SeeingGreen420 02/26/17 04:30:23 PM
#28121   I agree, but if you do some math ebota12 02/26/17 03:58:55 PM
#28120   I would imagine so, it is licensed as SeeingGreen420 02/26/17 03:38:20 PM
#28119   Why isn't Northern Vine listed on Health Canada's oatsuzn 02/26/17 03:10:34 PM
#28118   Yup, they have the option, do your DD SeeingGreen420 02/26/17 02:57:55 PM
#28117   Nope. StarFishPatrick 02/26/17 01:29:23 PM
#28116   Abattis began lab-minded. That was always the modus. GreenReality 02/26/17 01:27:51 PM
#28115   You have no idea if the "lab is StarFishPatrick 02/26/17 01:26:04 PM
#28114   All the assets Abattis has - due to StarFishPatrick 02/26/17 01:17:12 PM
#28113   Ding. Ding. Ding. StarFishPatrick 02/26/17 01:15:06 PM
#28112   Own enough to get the AGM materials etc. StarFishPatrick 02/26/17 01:14:33 PM
#28111   Yes, all signs point to trade being resumed SeeingGreen420 02/26/17 12:48:29 PM
#28110   Cease trade order may be lifted. Look at GreenReality 02/26/17 12:22:45 PM
#28109   Testing will be a keystone on the new GreenReality 02/26/17 12:12:10 PM
PostSubject